In a recent retrospective cohort study of 623 patients with AML, 63% of whom carried CHIP-related mutations, Calvillo et al. found an increased prevalence of cardiovascular diseases at baseline (72). The gene discussed is STUB1; the disease is cardiovascular disorder.